Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 13/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | CFD | P00746 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31435230 | 1.00 | ACKR3 (0.46) | ACKR3GSK3BMAPK14S1PR1GRM5 | |
| SCHEMBL31435267 | 0.88 | GSK3B (0.43) | ACKR3GSK3BMAPK14S1PR1ACHE | |
| SCHEMBL31435228 | 0.88 | GSK3B (0.43) | ACKR3GSK3BMAPK14S1PR1ACHE | |
| SCHEMBL31435222 | 0.87 | UBE2M (0.46) | ACKR3 | |
| SCHEMBL31435225 | 0.87 | UBE2M (0.46) | ACKR3 | |
| SCHEMBL31435231 | 0.87 | UBE2M (0.46) | ACKR3 | |
| SCHEMBL31435223 | 0.86 | ACKR3 (0.42) | ACKR3GSK3BMAPK14S1PR1 | |
| SCHEMBL31435264 | 0.86 | ACKR3 (0.42) | ACKR3GSK3BMAPK14S1PR1 | |
| SCHEMBL31435253 | 0.84 | S1PR1 (0.46) | S1PR1 | |
| SCHEMBL31435263 | 0.84 | S1PR1 (0.46) | S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090928-A1 | COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | AQUINNAH PHARMACEUTICALS, INC. (US) | 2025-05-01 | — | — | WO | disclosed |